$3.32
-0.12-3.49%
In chiusura: -
$3.33
0.010.30%
After hour: 6:27 PM EDT
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su X4 Pharmaceuticals Inc (NASDAQ:XFOR) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 1.55M a 1.89M. Questo rappresenta il 8.46% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in X4 Pharmaceuticals Corp (XNAS:XFOR) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 618.56K azioni scambiate al giorno, ci vorrebbero 3.06 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
1.89M
Vendite allo scoperto %
8.46%
Giorni di copertura
3.06
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
XFOR | X4 Pharmaceuticals, Inc. Commo | 09/15/2025 | 09/24/2025 | 8.46% | 22,362,691 | 1,892,311 | 618,562 | 3.06 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 08/29/2025 | 09/10/2025 | 6.95% | 22,362,691 | 1,554,621 | 2,549,093 | 1 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 08/15/2025 | 08/26/2025 | 11.03% | 22,362,691 | 2,466,929 | 16,995,141 | 1 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 07/31/2025 | 08/11/2025 | 14.40% | 7,092,322 | 1,021,497 | 2,717,708 | 1 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 07/15/2025 | 07/24/2025 | 5.50% | 7,092,322 | 390,377 | 527,856 | 1 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 06/30/2025 | 07/10/2025 | 5.31% | 7,092,322 | 376,874 | 440,414 | 1 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 06/13/2025 | 06/25/2025 | 8.48% | 5,714,304 | 484,831 | 439,308 | 1.1 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 05/30/2025 | 06/10/2025 | 6.95% | 5,714,304 | 396,893 | 185,380 | 2.14 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 05/15/2025 | 05/27/2025 | 5.47% | 5,714,304 | 312,303 | 179,764 | 1.74 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 04/30/2025 | 05/09/2025 | 5.09% | 5,714,304 | 290,703 | 142,275 | 2.04 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 04/15/2025 | 04/25/2025 | 5.13% | 171,429,124 | 8,798,612 | 1,858,663 | 4.73 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 03/31/2025 | 04/09/2025 | 4.71% | 171,429,124 | 8,075,118 | 1,847,051 | 4.37 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 03/14/2025 | 03/25/2025 | 5.11% | 169,037,788 | 8,641,381 | 1,509,932 | 5.72 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 02/28/2025 | 03/11/2025 | 5.61% | 169,037,788 | 9,480,584 | 1,316,431 | 7.2 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 02/14/2025 | 02/26/2025 | 6.54% | 169,037,788 | 11,061,185 | 2,416,416 | 4.58 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 01/31/2025 | 02/11/2025 | 9.82% | 169,037,788 | 16,606,425 | 10,403,264 | 1.6 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 01/15/2025 | 01/27/2025 | 8.02% | 169,037,788 | 13,550,472 | 3,136,688 | 4.32 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 12/31/2024 | 01/10/2025 | 7.90% | 169,037,788 | 13,360,196 | 2,811,619 | 4.75 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 12/13/2024 | 12/24/2024 | 7.81% | 169,037,788 | 13,204,412 | 4,669,519 | 2.83 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 11/29/2024 | 12/10/2024 | 7.40% | 169,037,788 | 12,501,447 | 2,224,217 | 5.62 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 11/15/2024 | 11/26/2024 | 7.65% | 169,037,788 | 12,938,054 | 7,759,538 | 1.67 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 10/31/2024 | 11/11/2024 | 6.84% | 166,990,833 | 11,424,210 | 1,322,431 | 8.64 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 10/15/2024 | 10/24/2024 | 7.58% | 166,990,833 | 12,658,228 | 1,340,088 | 9.45 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 09/30/2024 | 10/09/2024 | 8.12% | 166,990,833 | 13,562,227 | 766,513 | 17.69 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 09/13/2024 | 09/24/2024 | 8.16% | 166,990,833 | 13,621,228 | 625,225 | 21.79 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 08/30/2024 | 09/11/2024 | 9.12% | 166,990,833 | 15,225,650 | 908,477 | 16.76 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 07/31/2024 | 08/09/2024 | 8.84% | 166,429,100 | 14,715,092 | 1,460,740 | 10.07 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 07/15/2024 | 07/24/2024 | 9.92% | 166,429,100 | 16,505,651 | 2,837,339 | 5.82 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 06/28/2024 | 07/10/2024 | 8.34% | 166,429,100 | 13,882,654 | 4,506,045 | 3.08 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 06/14/2024 | 06/26/2024 | 7.16% | 166,429,100 | 11,920,391 | 1,333,578 | 8.94 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 05/31/2024 | 06/11/2024 | 7.14% | 166,429,100 | 11,877,895 | 1,131,788 | 10.49 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 05/15/2024 | 05/24/2024 | 7.34% | 166,429,100 | 12,213,183 | 3,229,510 | 3.78 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 04/30/2024 | 05/09/2024 | 7.92% | 166,429,100 | 13,185,538 | 5,313,495 | 2.48 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 04/15/2024 | 04/24/2024 | 7.37% | 166,429,100 | 12,264,810 | 2,889,733 | 4.24 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 03/28/2024 | 04/09/2024 | 7.36% | 167,479,268 | 12,333,789 | 5,586,525 | 2.21 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 03/15/2024 | 03/26/2024 | 8.49% | 167,479,268 | 14,222,812 | 1,723,213 | 8.25 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 02/29/2024 | 03/11/2024 | 8.62% | 166,976,082 | 14,395,571 | 1,420,488 | 10.13 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 01/31/2024 | 02/09/2024 | 7.67% | 166,832,696 | 12,796,124 | 1,208,036 | 10.59 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 01/12/2024 | 01/24/2024 | 7.19% | 166,832,696 | 11,992,749 | 1,135,620 | 10.56 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 12/29/2023 | 01/10/2024 | 6.96% | 166,832,696 | 11,619,191 | 1,434,847 | 8.1 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 12/15/2023 | 12/27/2023 | 7.04% | 166,832,696 | 11,742,525 | 5,282,459 | 2.22 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 11/30/2023 | 12/11/2023 | 6.85% | 166,832,696 | 11,422,413 | 1,506,786 | 7.58 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 11/15/2023 | 11/27/2023 | 6.87% | 166,832,696 | 11,453,084 | 2,462,997 | 4.65 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 10/31/2023 | 11/09/2023 | 7.02% | 163,966,384 | 11,507,869 | 1,619,318 | 7.11 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 10/13/2023 | 10/24/2023 | 6.64% | 163,966,384 | 10,880,191 | 1,129,603 | 9.63 | |
XFOR | X4 Pharmaceuticals, Inc. Commo | 09/29/2023 | 10/10/2023 | 6.47% | 163,966,384 | 10,615,289 | 1,049,040 | 10.12 |
In cerca di azioni più vendute allo scoperto?